I think one of the things that really swung me into NSB was the appointment of Professor Dao-Yi Yu to the scientific advisory board , from the Lions eye institute.
In my view this indicates a strong held belief from NSB, in the therapeutic benefits of Emtin-B, potentially becoming a leading drug treatment for eye diseases, such as glaucoma and other neurodegenerative diseases of the eye and brain..
But , I agree, it's going to be a relatively slow process..
AIMO...
GLTAH.
Potential 100 bagger Biotech missed by the market, page-156
-
- There are more pages in this discussion • 1,363 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
